Immune Checkpoint Inhibitors Clinical Trials
6 recruitingDrug
Phase 22Phase 11Phase 41
Showing 1–6 of 6 trials
Recruiting
Observational Cohort Study of Chronic Viral Infection in the Central Nervous System
Immune Checkpoint InhibitorsProgressive Multifocal Leukoencephalopathy
Peking Union Medical College Hospital66 enrolled1 locationNCT07512518
Recruiting
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Peking Union Medical College Hospital500 enrolled1 locationNCT07453342
Recruiting
Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Hospital Universitario Araba300 enrolled1 locationNCT07249060
Recruiting
Phase 2
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
Gastric Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology34 enrolled1 locationNCT06685887
Recruiting
Phase 1Phase 2
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
Esophageal Carcinoma
Anhui Provincial Hospital70 enrolled1 locationNCT05937438
Recruiting
Phase 4
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
Advanced Solid Tumor
University Hospital, Basel, Switzerland100 enrolled4 locationsNCT06408688